. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging. 2006 Mar;27(3):394-401. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. This is an important study that confirms and extends prior chemical AD biomarker studies of CSF isoprostanes and tau while combining them with MRI to improve diagnosis of MCI.

    The work is significant because it bodes well for the success of the recently funded AD Neuroimaging Study (see Practical Neurol., 3:30-34, 2004 and a PowerPoint summary. This study seeks to develop and validate an informative biomarker panel of both imaging parameters and chemical analytes in CSF, plasma, and urine that will enable distinction of AD from other dementias along the lines of Grossman et al., 2005 for AD versus frontotemporal dementia as well as prodromal AD from normal brain aging and the prodromal phases of other dementias.

    References:

    . Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol. 2005 May;57(5):721-9. PubMed.

This paper appears in the following:

News

  1. CSF Biomarkers Track With Atrophy, Cognition in Normal Aging